Jul 30, 2015
arGEN-X and University of Bern enter into license agreement to develop ARGX-110-based combination therapies for treatment-resistant cancers
Jul 15, 2015
Change to the Board of Directors
More News

Aug 12, 2015
Wedbush PacGrow Healthcare Conference
New York City, USA
Aug 18-19, 2015
3rd Annual MD Anderson Event
Houston, USA
All Events